European Health & Pharmaceutical Law Review - EHPL
The EHPL – European Health & Pharmaceutical Law identifies and analyses important legal and regulatory developments on the national, EU and international level. It is primarily concerned with pharmaceutical law, medicines law and issues related to the work of the European Medicines Agency (EMA).
Furthermore, it provides an overview of and critically examines judgments and directives that shape the interpretation and application of EU pharmaceutical law and policy, including those by the European Medicines Agency (EMA), European Courts, international courts and tribunals such as the WTO’s Dispute Settlement Body, and higher national courts.
Bestellen Sie hier:
Jahresabonnement | Reduzierte Abos | |||||
---|---|---|---|---|---|---|
Inland | Ausland | Institution | Probeabo | Studentenabo | ||
529,65 € | 495,00 € | 178,69 € | ||||
Jahresabonnement | Einzelheft | |||||
Digital | Print + Digital | Ladenpreis | ||||
529,65 € | 618,46 € | |||||
Erscheinung | Auflage | |||||
Turnus | verkauft | verbreitet | ||||
Verlag / Anschrift | aktualisiert am | Seitenaufrufe | ||||
---|---|---|---|---|---|---|
Lexxion Verlagsgesellschaft mbH | 05.03.2024 | 30 | ||||
Güntzelstraße 63 , 10717 Berlin | ||||||
Ansprechpartner | Yushi Jiang | |||||
030 - 81 45 06 0 | 030 - 81 45 06 22 | |||||
Anzeigenannahme | Yushi Jiang | |||||
+49 30 81 45 06 18 | +49 30 81 45 06 22 | |||||
Redaktion | Jakob McKernan | |||||
+49 30 81 45 06 10 | +49 30 81 45 06 22 |